Aryana Libris

Authors : Dixit Sanjay - Pandey Deep Narayan
Title : The science behind the magic of Ayurveda Clinical studies on medicinal plants included in the polyherbal formulation JVN-8
Year : 2015

Link download : Dixit_Sanjay_-_The_science_behind_the_magic_of_Ayurveda.zip

Introduction. Age-related onset of pathogenesis presents a substantial healthcare and economic challenge before the global society. The world is headed to a situation in which by the year 2050 there will be the same number of old as young, with 2 billion people aged 60 or over and another 2 billion under age 15, each group accounting for 21% of the world’s population. It is well known that 63% of all deaths worldwide currently emanate from non-communicable diseases, mainly cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. These diseases pose a rising and substantial economic burden both in terms of healthcare costs and lost workdays. For example, with respect to cardiovascular disease, chronic respiratory disease, cancer, diabetes and mental health, studies suggest a cumulative output loss of US$ 47 trillion over the next two decades. This loss equals 75% of global GDP in 2010 (US$ 63 trillion). It also represents enough money that can eradicate two-dollar-a-day poverty among the 2.5 billion who remained poor for more than half a century. Global community is now trying to find out the sustainable solutions to agerelated onset of fatal diseases across various healthcare systems. Accordingly, we posed a question to ourselves; if Ayurveda, the world's most comprehensive, personalized, holistic and sustainable healthcare system can provide solutions to substantially delay the age-related pathogenesis? In other words, if you do not suffer from a critical illness today, is it possible to remain healthy for substantial period of life or is it possible to increase health span? We hypothesized that the answer may be, yes. Some caveats need to be made clear upfront. First, while the drug we intended to develop is aimed at addressing the challenges of advancing age, these efforts are not to be termed as anti-aging. The drug is not intended to increase the life-span; rather it is aimed at extending the health span (i.e., healthy and disease-free years in our life). Second, the dream is to develop a drug accessible to rich and poor alike, meaning thereby that it should fulfil both the criteria of cost as well as ease of production. ...